 Azithromycin
"Azithromycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.
| Descriptor ID |
D017963
|
| MeSH Number(s) |
D02.540.576.500.992.050
|
| Concept/Terms |
Zithromax- Zithromax
- Azitrocin
- Azadose
- Ultreon
- Zitromax
|
Below are MeSH descriptors whose meaning is more general than "Azithromycin".
Below are MeSH descriptors whose meaning is more specific than "Azithromycin".
This graph shows the total number of publications written about "Azithromycin" by people in this website by year, and whether "Azithromycin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2010 | 0 | 1 | 1 | | 2011 | 2 | 0 | 2 | | 2012 | 2 | 0 | 2 | | 2013 | 1 | 1 | 2 | | 2014 | 1 | 1 | 2 | | 2015 | 5 | 1 | 6 | | 2016 | 3 | 0 | 3 | | 2017 | 1 | 0 | 1 | | 2018 | 1 | 1 | 2 | | 2019 | 3 | 2 | 5 | | 2020 | 2 | 1 | 3 | | 2021 | 3 | 5 | 8 | | 2022 | 1 | 2 | 3 | | 2023 | 1 | 3 | 4 | | 2024 | 2 | 2 | 4 | | 2025 | 2 | 5 | 7 | | 2026 | 4 | 1 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Azithromycin" by people in Profiles.
-
Hibberd PL, Kim JH, Trotta M, Leal SM, Aceituno A, Ward DV, Patel A, Subramaniam A, Carlo WA, Ahmed I, Saleem S, Billah SM, Haque R, Mazariegos M, Esamai F, Somannavar MS, Goudar SS, Chomba E, Mwenchanya M, Lokangaka A, Tshefu A, Goldenberg RL, Bauserman M, Krebs NF, Bucher S, Derman RJ, Petri WA, Koso-Thomas M, Babineau DC, McClure EM, Tita ATN. Impact of prophylactic oral azithromycin during labor on Azithromycin Resistance (AMR) in nasal Staphylococcus aureus and Streptococcus pneumoniae in women and infants in the multi-country Azithromycin Prevention in Labor Use Study (A-PLUS). PLoS One. 2026; 21(4):e0346174.
-
Daley CL, van Ingen J, Chalmers JD, Flume PA, Griffith DE, Hasegawa N, Morimoto K, Winthrop KL, Sheu CC, Avsar K, Andrisani D, Codecasa LR, Terschlüsen E, May D, Yuen DW, Wu P, Hassan M, Nevoret ML, Mange K. Amikacin liposome inhalation suspension in newly diagnosed Mycobacterium avium complex lung disease (ARISE): a 6-month double-blind, active comparator trial. Ann Am Thorac Soc. 2026 04 01; 23(4):536-547.
-
Sidze L, Moore JL, Carlo WA, Mwenechanya M, Chomba E, Hemingway-Foday JJ, Kavi A, Metgud MC, Goudar SS, Derman R, Lokangaka AL, Tshefu AK, Bauserman MS, Bose CL, Shivkumar P, Waikar M, Patel AB, Hibberd PL, Nyongesa P, Esamai F, Ekhaguere OA, Bucher SL, Jessani S, Tikmani SS, Saleem S, Goldenberg RL, Billah SM, Lennox R, Haque R, Petri WA, Figueroa L, Mazariegos M, Krebs NF, Nolen TL, Koso-Thomas M, McClure EM, Tita ATN. Intrapartum oral azithromycin for maternal infection prophylaxis and the risk of postpartum hemorrhage: A secondary analysis of the A-PLUS trial. Int J Gynaecol Obstet. 2026 Jun; 173(3):1562-1568.
-
McClure EM, Tita ATN, Carlo WA, Saleem S, Moore JL, Jessani S, Tikmani SS, Shivkumar P, Waikar MR, Patel A, Mwenechanya M, Chomba E, Kavi A, Metgud MC, Goudar SS, Lokangaka A, Tshefu A, Nyongesa P, Esamai F, Haque R, Billah SM, Derman RJ, Bauserman M, Bose CL, Hibberd PL, Ekhaguere OA, Bucher S, Petri WA, Mazariegos M, Krebs NF, Asturias EJ, Hemingway-Foday JJ, Babineau DC, Koso-Thomas M, Goldenberg RL. Non-study post-partum antibiotics use and risk of maternal and neonatal infection: A secondary analysis of the A-PLUS randomized controlled trial. Int J Gynaecol Obstet. 2026 Jun; 173(3):1362-1371.
-
Boelig RC, Kavi A, Moore JL, Babineau DC, Metgud MC, Somannavar MS, Goudar SS, Derman RJ, Sunder Tikmani S, Saleem S, Goldenberg RL, Lokangaka AL, Tshefu AK, Bauserman MS, Mwenechanya M, Chomba E, Mazariegos M, Figueroa L, Krebs NF, Nyongesa P, Esamai F, Bucher S, Patel AB, Hibberd PL, Petri WA, Billah SM, Haque R, Koso-Thomas M, McClure EM, Carlo WA, Tita ATN. Timing of Prophylactic Intrapartum Azithromycin Administration and Efficacy in Prevention of Maternal and Infant Infections: A Secondary Analysis of a Randomized Controlled Trial. BJOG. 2026 Apr; 133(5):976-984.
-
Sagel SD, Vu P, Heltshe SL, Solomon GM, Kelly A, Pittman J, Rosenfeld M, Ratjen F. Elexacaftor/tezacaftor/ivacaftor is associated with long-term reduction in use of chronic respiratory therapies in cystic fibrosis. J Cyst Fibros. 2026 May; 25(3):450-456.
-
Weber MJ, MacBrayne CE, Bakel LA, Ambroggio L, Cotter JM, Birkholz M, Poole NM. Clinical Pathway Revision Increases Amoxicillin Monotherapy and 5-Day Durations of Therapy for Pediatric Community-Acquired Pneumonia in the Emergency Department and Urgent Care: A Quality Improvement Initiative. Ann Emerg Med. 2025 12; 86(6):586-593.
-
El Feghaly RE, Herigon J, Wattles BA, Kronman MP, Smith MJ, Patel SJ, Poole NM, Olivero R, Wirtz AL, Lee BR. Identifying successful pediatric outpatient antimicrobial stewardship strategies through benchmarking: A multi-institutional project. Am J Infect Control. 2025 Dec; 53(12):1313-1319.
-
Patterson JK, Neuwahl S, Kirsch S, Moore JL, Tita ATN, Carlo WA, Lokangaka A, Tshefu A, Mwenechanya M, Chomba E, Kavi A, Metgud MC, Goudar SS, Derman RJ, Shivkumar P, Waikar M, Patel A, Hibberd PL, Nyongesa P, Esamai F, Ekhaguere OA, Bucher S, Jessani S, Tikmani SS, Saleem S, Wylie BJ, Goldenberg RL, Billah SM, Lennox R, Haque R, Petri WA, Mazariegos M, Krebs NF, Hemingway-Foday JJ, Babineau D, Koso-Thomas M, McClure EM, Bauserman M. Cost-effectiveness of intrapartum azithromycin to prevent maternal infection, sepsis, or death in low-income and middle-income countries: a modelling analysis of data from a randomised, multicentre, placebo-controlled trial. Lancet Glob Health. 2025 04; 13(4):e679-e688.
-
Carlo WA, Tita ATN, Moore JL, Mwenechanya M, Chomba E, Hemingway-Foday JJ, Kavi A, Metgud MC, Goudar SS, Derman RJ, Lokangaka A, Tshefu A, Bauserman M, Patterson JK, Shivkumar P, Waikar M, Patel A, Hibberd PL, Nyongesa P, Esamai F, Ekhaguere OA, Bucher S, Jessani S, Tikmani SS, Saleem S, Goldenberg RL, Billah SM, Lennox R, Haque R, Petri W, Mazariegos M, Krebs NF, Babineau DC, McClure EM, Koso-Thomas M. Effectiveness of intrapartum azithromycin to prevent infections in planned vaginal births in low-income and middle-income countries: a post-hoc analysis of data from a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Glob Health. 2025 04; 13(4):e689-e697.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|